BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/23/2021 2:14:14 PM | Browse: 196 | Download: 471
 |
Received |
|
2021-07-04 09:00 |
|
Peer-Review Started |
|
2021-07-04 09:04 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-09-28 07:13 |
|
Revised |
|
2021-09-29 16:03 |
|
Second Decision |
|
2021-11-16 03:29 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-11-18 06:40 |
|
Articles in Press |
|
2021-11-18 06:40 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-12-09 09:24 |
|
Publish the Manuscript Online |
|
2021-12-23 14:14 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Dramatic response to immunotherapy in an epidermal growth factor receptor-mutant non-small cell lung cancer: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ding Li, Cheng Cheng, Wen-Ping Song, Pei-Zan Ni, Wen-Zhou Zhang and Xuan Wu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Henan Provincial Science and Technology Research Project |
202102310157 |
| Medical Science and Technology Research Plan (Joint Construction) Project of Henan Province |
LHGJ20190676 |
|
| Corresponding Author |
Xuan Wu, MD, Doctor, Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No. 127 Dongming Road, Zhengzhou 450008, Henan Province, China. 843240113@qq.com |
| Key Words |
Epidermal growth factor receptor mutation; Non-small cell lung cancer; Pemetrexed; Immunotherapy; Case report |
| Core Tip |
In this paper, we report a patient with metastatic epidermal growth factor receptor-mutant non-small cell lung cancer showed dramatic response to immunotherapy after pemetrexed plus carboplatin and achieved a durable disease control over 10 mo. We aimed to analyze the potential reasons why the patient can benefit from immunotherapy and explore the strategy that should be adopted in the future. |
| Publish Date |
2021-12-23 14:14 |
| Citation |
Li D, Cheng C, Song WP, Ni PZ, Zhang WZ, Wu X. Dramatic response to immunotherapy in an epidermal growth factor receptor-mutant non-small cell lung cancer: A case report. World J Clin Cases 2021; 9(36): 11419-11424 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i36/11419.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i36.11419 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
